dPCR and qPCR market growth is driven mainly by the rising incidence
of target infectious diseases and genetic disorders; technological
advancements in PCR technologies; increasing investments, funds, and
grants; increasing use of biomarker profiling for disease diagnostics;
and successful completion of the Human Genome Project.
The global dPCR and qPCR market size is projected to reach $7.6 billion by 2025 from $4.9 billion in 2020, at a CAGR of 9.0%.
North
America accounted for the largest share of the global dPCR and qPCR
market, followed by North America. The large share of the North American
Digital PCR Market is attributed to the increased adoption of
innovative and novel genomic analysis products (including advanced qPCR
and dPCR products), availability of RD funding for genomic research
(coupled with the robust research infrastructure in the region),
expanding use of PCR techniques in clinical diagnostics forensics, and
early commercialization of qPCR/dPCR products compared to other regions.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204
Digital PCR (dPCR) and Real-time PCR (qPCR) – Market- Report Highlights
“The
market for dPCR and qPCR is expected to witness robust growth during
the forecast period, compared with the previous estimates of this market
due to belowentioned reasons”
◉ Increase in the number of US FDA Emergency Use Approvals (EUA) for PCR-based COVID-19 tests
◉ Increase in demand for PCR-based COVID-19 tests
◉
The current edition of the report consists of the impact of COVID-19 on
the market (in the research methodology chapter, region-wise impact in
the geographic analysis section, and the impact on end users).
◉
Additional points in the market overview section have been added,
keeping in mind the impact of COVID-19 on the overall market.
◉ The
competitive landscape chapter has been updated with the market
evaluation matrix. The competitive landscape also includes the market
share analysis, updated competitive leadership mapping, and competitive
situations and trends.
◉ New and improved representation of financial
information: The new edition of the report provides updated financial
information till 2019 (depending on the availability) for each listed
company in the graphical representation. This would help in the easy
analysis of the present status of profiled companies in terms of their
financial strength, profitability, key revenue-generating
region/country, and business segment focus in terms of the highest
revenue-generating segment.
OPPORTUNITY: Growing market penetration in emerging countries
Emerging
markets are expected to offer significant growth opportunities due to
the rising incidence of infectious and chronic diseases as well as
increasing RD initiatives to develop innovative genomic techniques such
as qPCR and dPCR. The growth in these dPCR and qPCR market is supported
by the expansion of healthcare infrastructure, increase in healthcare
expenditure, and reducing procedural costs for qPCR and dPCR-based
disease diagnosis. Emerging countries are witnessing rapid modernization
in healthcare facilities and the expansion of healthcare
infrastructure. This factor is contributing to the growing demand for
clinical diagnostic procedures among diagnostic laboratories, which is
resulting in the increased sales of clinical qPCR and dPCR products.
Thermo
Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), and F.
Hoffmann-La Roche, Ltd. (Switzerland) are the key players operating in
this market.
This market research study involved the extensive
use of secondary sources, directories, and databases to identify and
collect information useful for this technical, market-oriented, and
financial study of the global dPCR and qPCR market. In-depth interviews
were conducted with various primary respondents, including key industry
participants, subject-matter experts (SMEs), C-level executives of key
market players, and industry consultants, to obtain and verify critical
qualitative and quantitative information and to assess market prospects.
The size of the dPCR and qPCR market was estimated through various
secondary research approaches and triangulated with inputs from primary
research to arrive at the final market size.
Browse in-depth TOC on “Digital PCR Market”
253 – Tables
41 – Figures
316 – Pages
https://www.marketsandmarkets.com/Market-Reports/digital-pcr-market-174151204.html
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
sales@marketsandmarkets.com
